Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Weed (BUDZ) Cash & Equivalents (2017 - 2025)

Weed has reported Cash & Equivalents over the past 9 years, most recently at $33130.0 for Q4 2025.

  • Quarterly results put Cash & Equivalents at $33130.0 for Q4 2025, down 79.21% from a year ago — trailing twelve months through Dec 2025 was $33130.0 (down 79.21% YoY), and the annual figure for FY2025 was $33130.0, down 79.21%.
  • Cash & Equivalents for Q4 2025 was $33130.0 at Weed, up from $400.0 in the prior quarter.
  • Over the last five years, Cash & Equivalents for BUDZ hit a ceiling of $821094.0 in Q2 2022 and a floor of $400.0 in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $38602.0 (2021), compared with a mean of $167308.9.
  • Biggest five-year swings in Cash & Equivalents: surged 30695.11% in 2022 and later plummeted 99.17% in 2024.
  • Weed's Cash & Equivalents stood at $1739.0 in 2021, then surged by 18061.36% to $315826.0 in 2022, then decreased by 8.05% to $290409.0 in 2023, then crashed by 45.13% to $159355.0 in 2024, then tumbled by 79.21% to $33130.0 in 2025.
  • The last three reported values for Cash & Equivalents were $33130.0 (Q4 2025), $400.0 (Q3 2025), and $5350.0 (Q2 2025) per Business Quant data.